Currently, people who live with amyotrophic lateral sclerosis (ALS) do not have an efficient treatment, since we do not know the mechanisms of the disease. People diagnosed with this neurodegenerative disease, which manifests itself in adulthood, have an average survival of three years. Patients lose …